The Outlook article 'Research without prejudice' (Nature 525, S12–S13; 2015) incorrectly stated that the approval of the US National Institute on Drug Abuse (NIDA) is required for US cannabis trials. In fact, NIDA provides cannabis for every project that has completed the government-mandated approval process. The article also implied that NIDA was holding up the start of a trial led by Sue Sisley, but the delay is caused by other circumstances.
Additional information
The online version of the original article can be found at 10.1038/525S12a
Rights and permissions
About this article
Cite this article
Correction. Nature 528, 333 (2015). https://doi.org/10.1038/528333f
Published:
Issue Date:
DOI: https://doi.org/10.1038/528333f
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
